- Home
- CRDO vs BDX Comparison
CRDO vs BDX Comparison
Compare CRDO & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDO | BDX |
|---|---|---|
| Founded | 2008 | 1897 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7B | 43.0B |
| IPO Year | 2022 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CRDO | BDX |
|---|---|---|
| Price | $230.73 | $192.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $179.62 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 4.8M | 1.8M |
| Earning Date | 06-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ 765.52 | N/A |
| EPS | ★ 2.51 | 1.59 |
| Revenue | $1,335,116,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $210.92 | N/A |
| Revenue Next Year | $57.22 | $3.02 |
| P/E Ratio | ★ $91.94 | $118.03 |
| Revenue Growth | ★ 205.68 | 8.24 |
| 52 Week Low | $86.49 | $140.11 |
| 52 Week High | $308.67 | $213.08 |
Technical Indicators
Market Signals| Indicator | CRDO | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.94 | 77.15 |
| Support Level | $225.66 | $190.78 |
| Resistance Level | $241.14 | $196.05 |
| Average True Range (ATR) | 19.27 | 4.38 |
| MACD | -0.73 | 0.75 |
| Stochastic Oscillator | 27.59 | 97.80 |
Price Performance
Historical ComparisonAbout CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.